NCT03458312

Brief Summary

Patients diagnosed with high-grade gliomas (HGG) experience a complex symptom burden including high-levels concerns. As a consequence to this life-threatening disease, the rely on close contact with a specialized neuro-oncological team as well as support and practical assistance from their families. However, multidimensional burden of caregivers has been reported. CARES seeks to facilitate and activate the existing resources within the patient and the network using a new model of systematic family care approach. Specialized neuro-oncological nurses are responsible for an expanded area providing an opportunity for the nursing profession to establish a new model of nursing care. This may not only benefit the patients and their families but also contribute to strengthen the nurses' professional identity and support further development of neuro-oncological specialist team.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 8, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

April 9, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

2.2 years

First QC Date

January 5, 2018

Last Update Submit

November 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The experiences from participation in Family and network consultations (FNC)

    Interviews seek the perspectives on the life situation related to the participation of FNC

    At week 50 to 52

Secondary Outcomes (7)

  • Change in the perceived Caregiver Burden Scale over time (only caregivers)

    At week 1-2, week 8-10, week 28-30 and week 50-52

  • Change in the severity of depressive symptoms over time measured by the Hospital Anxiety and Depression Scale (HADS)

    At week 1-2, week 8-10, week 28-30 and week 50-52

  • Change in the severity of anxiety over time measured by the Hospital Anxiety and Depression Scale (HADS)

    At week 1-2, week 8-10, week 28-30 and week 50-52

  • Changes in the perception of received support from nurses will be measured by the ICE Family Perceived Support Questionnaire (ICE-FPSQ) (caregiver and patient, individually)

    At week 1-2, week 8-10, week 28-30 and week 50-52

  • The perceived changes of the functioning within a Family will be measured by the Psychometric development of the Iceland-Expressive Family Functioning Questionnaire (ICE-EFFQ) (caregiver and patient, individually)

    At week 1-2, week 8-10, week 28-30 and week 50-52

  • +2 more secondary outcomes

Other Outcomes (1)

  • Change in the perception of the nurses professional identity

    At week 28-30 and week 50-52

Study Arms (2)

Family and Network support measurements

NO INTERVENTION

The perceived 'Family support' and 'Caregiver burden' (FNC) will be measured among 30 families. Test time points: Post 1. FNC (week 1-2), post FNC 2 (week 8-10) and post FNC 3 (week 28-30) and post the 4. FNC (week 50-52)

Family and network consultations

EXPERIMENTAL

Intervention: FNC IG will receive four family consultations over 52 weeks relying on the Calgary model and Patient-reported outcome on symptom management and concerns.

Behavioral: Family and Network Consultations

Interventions

Family and Network Consultation' (FNC) seek to identify and address patients' symptoms/concerns and caregiver burden on one side and identify the resources and opportunities to ease their burdens on the other side. Intervention: FNC IG will receive four family consultations over 52 weeks relying on the Calgary model and Patient-reported outcome on symptom management and concerns.

Family and network consultations

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients in the cohort (n=30) and IG (n=30) and their families will be recruited within the first week after surgery. Included are:
  • Patients ≥ 18 years of age and newly diagnosed with HGG (WHO classification grade III/IV) after biopsy or operation.
  • The patients and their family members and network must be able to speak and understand Danish.
  • Provide informed consent

You may not qualify if:

  • Excluded are • Patients without family or any network. There are no restrictions regarding the family members/network relation to the patient as long as the patient has accepted the person(s) as being a close relative or friend that the patient allows to participate in the FNC. Written informed consent will be obtained before discharge from the hospital or by telephone after discharge.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital of Copenhagen, Rigshospitalet

Copenhagen, 2100, Denmark

Location

Related Publications (1)

  • Piil K, Laegaard Skovhus S, Tolver A, Jarden M. Neuro-Oncological Symptoms: A Longitudinal Quantitative Study of Family Function, Perceived Support, and Caregiver Burden. J Fam Nurs. 2022 Feb;28(1):43-56. doi: 10.1177/10748407211029986. Epub 2021 Jul 21.

MeSH Terms

Conditions

Glioma

Condition Hierarchy (Ancestors)

Neoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Glandular and EpithelialNeoplasms, Nerve Tissue

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
a sample of patients with HGG (n=30) and their caregivers (n=30) recruited for intervention group (IG) with 'Nurse-led Family and Network Consultations' using pretest and posttest measures.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: To explore the feasibility of a 'Nurse-led Family and Network Consultation' (FNC) that seek to identify and address patients' symptoms/concerns and caregiver burden on one side and identify the resources and opportunities to ease their burdens on the other side. To explore the impact of these nurse consultations on the nurses' perception of autonomy, self-esteem, and confidence, representing their professional identity
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D. Research and quality manager

Study Record Dates

First Submitted

January 5, 2018

First Posted

March 8, 2018

Study Start

April 9, 2018

Primary Completion

July 1, 2020

Study Completion

November 1, 2023

Last Updated

November 28, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations